India's Morepen makes first test batch of Russia's Sputnik V shot - fund

Reuters, 06.07.2021

MOSCOW, July 6 (Reuters) - Indian drug manufacturer Morepen Laboratories has begun production of the Russian Sputnik V coronavirus vaccine, the Russian Direct Investment Fund (RDIF), responsible for marketing the shot internationally, said on Tuesday.

The first test batch made by the Indian manufacturer in the state of Himachal Pradesh will be shipped to Gamaleya, the Moscow institute which developed the vaccine, for quality controls, RDIF said in a statement.